Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Antibiotic-resistant bacteria share resources to cause chronic infections, show studies

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt University investigators have discovered.

20 Oct 2014

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience. The Montréal scientists discovered that a protein found in the retina plays an essential role in the function and survival of light-sensing cells that are required for vision.

16 Oct 2014

New treatment strategy may improve repair process after heart attack

In a study that could point the way toward a new strategy for treating patients after a heart attack, UCLA stem cell researchers led by associate professor of medicine (cardiology) and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research member Dr. Arjun Deb have discovered that some scar-forming cells in the heart, known as fibroblasts, have the ability to become endothelial cells (the cells that form blood vessels).

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Tannic acid may help ease impact of bacterial lung infections in CF patients

By screening over 2,000 approved drugs and natural products, scientists have shown that tannic acid may help ease the impact of bacterial lung infections in cystic fibrosis patients.

14 Oct 2014

International Biophysics files patent protection for revolutionary AffloVest

International Biophysics Corporation of Austin, Texas announces its filing of U.S. patent protection for its revolutionary AffloVest. The company has also recently confirmed exclusive ownership rights concerning the manufacture, sale and distribution of the AffloVest in its markets.

9 Oct 2014

Pediatric specialist in EGIDs helps lead $6.25 million NIH clinical research project

A pediatric specialist in eosinophilic gastrointestinal diseases (EGIDs) at the University of Colorado School of Medicine and Children's Hospital Colorado will help lead a five-year, $6.25 million clinical research project recently funded by the National Institutes of Health.

9 Oct 2014

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.

8 Oct 2014

Childhood eating disorders could have underlying psychological issues, researchers warn

Researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital are warning parents that difficult eaters could have underlying psychological issues, as they have found that restrictive behaviours can appear before puberty.

8 Oct 2014

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company, has announced the launch of its lead product Rasuvo (methotrexate) injection for patients with rheumatoid arthritis (RA), poly-articular-course juvenile idiopathic arthritis (pJIA) and psoriasis in the U.S.

6 Oct 2014

IRCM researchers discover mechanism that promotes progression of medulloblastoma

Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Fr-d-ric Charron, PhD, found that a protein known as Sonic Hedgehog induces DNA damage, which causes the cancer to develop.

3 Oct 2014

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody.

30 Sep 2014

OSU engineers develop simple device to improve hand function after surgery

Engineers at Oregon State University have developed and successfully demonstrated the value of a simple pulley mechanism to improve hand function after surgery.

29 Sep 2014

Leading Cystic Fibrosis experts call for greater research on antibacterial resistance

World leading Cystic Fibrosis experts, from Queen's University Belfast, have called for greater research to address the major concern of antibacterial resistance.

29 Sep 2014

Study demonstrates longer-term benefits of Lung Flute for COPD patients

Patients with chronic obstructive pulmonary disease (COPD) report improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute-, according to a new study by the University at Buffalo. Usually caused by smoking, COPD, which includes chronic bronchitis and emphysema, is the third leading cause of death in the U.S.

29 Sep 2014

US children with cystic fibrosis have better lung function compared to UK counterparts

There are significant differences in the lung function of children and young adults in the United States (US) who have cystic fibrosis compared with those in the United Kingdom (UK).

27 Sep 2014

Sheffield Teaching Hospitals NHS Foundation Trust nominated twice for Health Service Journal Awards

SHEFFIELD Teaching Hospitals NHS Foundation Trust has been nominated twice for outstanding ideas improving patient care in the Health Service Journal Awards 2014 – one of the most coveted awards in healthcare.

27 Sep 2014

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.

25 Sep 2014

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

23 Sep 2014

Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Study after study has proven it true: exercise is good for you. But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy.

19 Sep 2014

Fibrosis News and Research

Further Reading

Antibiotic-resistant bacteria share resources to cause chronic infections, show studies

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

New treatment strategy may improve repair process after heart attack

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Tannic acid may help ease impact of bacterial lung infections in CF patients

International Biophysics files patent protection for revolutionary AffloVest

Pediatric specialist in EGIDs helps lead $6.25 million NIH clinical research project

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Childhood eating disorders could have underlying psychological issues, researchers warn

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

IRCM researchers discover mechanism that promotes progression of medulloblastoma

Allakos secures additional $10M investment to expand its development portfolio

OSU engineers develop simple device to improve hand function after surgery

Leading Cystic Fibrosis experts call for greater research on antibacterial resistance

Study demonstrates longer-term benefits of Lung Flute for COPD patients

US children with cystic fibrosis have better lung function compared to UK counterparts

Sheffield Teaching Hospitals NHS Foundation Trust nominated twice for Health Service Journal Awards

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News